Calendar · pharmadog

Sign In Subscribe

Week of Feb 16, 2026

50

Feb 17, 2026approval182d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval182d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval182d agoIDELALISIB — FDA approvalIDELALISIB

Sponsor: NATCO. Form: TABLET. Route: ORAL

full page →IDELALISIB →fda approvals ↗

Feb 17, 2026approval182d agoAMBRISENTAN — FDA approvalAMBRISENTAN

Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

full page →AMBRISENTAN →fda approvals ↗

Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval182d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval182d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

full page →SODIUM PHENYLBUTYRATE →fda approvals ↗

Feb 17, 2026approval182d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Feb 17, 2026approval182d agoCOLCHICINE — FDA approvalCOLCHICINE

Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

full page →COLCHICINE →fda approvals ↗

Feb 17, 2026approval182d agoAMBRISENTAN — FDA approvalAMBRISENTAN

Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

full page →AMBRISENTAN →fda approvals ↗

Feb 17, 2026approval182d agoMEDICAL AIR, USP — FDA approval

Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

full page →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval182d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval182d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Feb 17, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval182d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval182d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval182d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval182d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval182d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

Feb 17, 2026grant182d agoCHILDREN'S HOSP OF PHILADELPHIA — Role of the PilC1 and PilC2 pilus-associated proteins in Kingella kingae path...PATH

AI grant. $853,112. PI: Joseph W. St. Geme

full page →nih reporter ↗

Feb 17, 2026grant182d agoWASHINGTON STATE UNIVERSITY — Role of Fn-14 receptor in TNF-induced inflammation and tissue destruction

AI grant. $497,779. PI: Salah-uddin Ahmed

full page →nih reporter ↗

Feb 17, 2026grant182d agoUNIVERSITY OF TEXAS DALLAS — Disruption of a DNA Repair Protein Promotes Antibiotic Resistance in Acinetob...

AI grant. $434,625. PI: Nicholas A Dillon

full page →nih reporter ↗

Feb 17, 2026grant182d agoUNIVERSITY OF PENNSYLVANIA — The 22nd International Vasculitis WorkshopUniversity of Pennsylvania

TR grant. $18,000. PI: Peter A Merkel

full page →nih reporter ↗

Feb 17, 2026grant182d agoUNIVERSITY OF CALIFORNIA-IRVINE — Vancomycin-Teixobactin Conjugates

AI grant. $404,866. PI: JAMES S NOWICK

full page →nih reporter ↗

Feb 17, 2026grant182d agoDUKE UNIVERSITY — Identifying Endocrine-Disrupting Plastic Additives using Machine LearningDuke University

ES grant. $444,125. PI: Daniel Reker

full page →nih reporter ↗

Feb 17, 2026grant182d agoJOHNS HOPKINS UNIVERSITY — Modification of the predisposition for ectopic calcificationJohns Hopkins University

OD grant. $388,750. PI: Shira G Ziegler

full page →nih reporter ↗

Feb 17, 2026grant182d agoDUKE UNIVERSITY — Understanding environmental mitochondrial healthDuke University

ES grant. $1,006,211. PI: Joel Newman Meyer

full page →nih reporter ↗

Feb 17, 2026grant182d agoJOHNS HOPKINS UNIVERSITY — Generating Critical Knowledge on the NMP Peptide Signaling in the Peripheral ...Johns Hopkins University

NS grant. $232,938. PI: SETH S MARGOLIS

full page →nih reporter ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval181d agoARBLI (LOSARTAN POTASSIUM) — FDA approvalLOSARTAN POTASSIUM

Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval181d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval181d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →aripiprazole LA →fda approvals ↗

Feb 18, 2026approval181d agoEBANGA (ANSUVIMAB-ZYKL) — FDA approvalansuvimab

Sponsor: RIDGEBACK BIOTHERAPEUTICS. Form: POWDER. Route: IV (INFUSION)

full page →ansuvimab →fda approvals ↗

Feb 18, 2026approval181d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: IPCA LABS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026grant181d agoBAYLOR COLLEGE OF MEDICINE — Defining the molecular mechanisms driving transovarial transmission of Acari-...Baylor College of Medicine

AI grant. $797,087. PI: Job E Lopez

full page →nih reporter ↗

Feb 18, 2026grant181d agoMCLEAN HOSPITAL — Online social networking mechanisms of suicide in adolescents

MH grant. $193,320. PI: Julianne G. Wilner

full page →nih reporter ↗

← prev

page 1 of 44